V. Lawlis
Director/Board Member chez GERON CORPORATION
Fortune : 3 M $ au 31/03/2024
Profil
V.
Bryan Lawlis is the founder of Itero Biopharmaceuticals, Inc. (founded in 2007), Covance Biotechnology Services, Inc. (founded in 1996), and Itero Biopharmaceuticals LLC (founded in 2011).
He held the titles of President & Chief Executive Officer at Itero Biopharmaceuticals, Inc. from 2007 to 2011, Chairman at Covance Biotechnology Services, Inc. from 1999 to 2001, and President & Chief Executive Officer at Itero Biopharmaceuticals LLC from 2011 to 2017.
His current job(s) include being an Independent Director at Geron Corp.
since 2012, an Independent Non-Executive Director at BioMarin Pharmaceutical, Inc. since 2007, a Director at ReForm Biologics LLC, a Director at Tspan LLC since 2017, and a Director at Comera Life Sciences, Inc.His former job(s) include being the Chief Executive Officer & Director at Aradigm Corp.
from 2001 to 2006, President & Chief Executive Officer at Itero Holdings LLC from 2011 to 2017, a Director at Humanigen, Inc. from 2013 to 2014, an Independent Director at Sutro Biopharma, Inc. from 2003 to 2019, an Independent Director at Spyre Therapeutics, Inc. from 2018 to 2023, a Director at GlycoFi, Inc., an Independent Director at Coherus BioSciences, Inc. from 2014 to 2021, an Independent Director at Absci Corp., and a Director at Comera Life Sciences Holdings, Inc. He also held the position of Vice President-Process Sciences at Genentech, Inc. from 1981 to 1996 and Senior Scientist at Genencor International, Inc. in 1996.
Dr. Lawlis obtained an undergraduate degree from The University of Texas at Austin and a doctorate degree from Washington State University in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/05/2023 | 33 140 ( 0,02% ) | 3 M $ | 31/03/2024 | |
GERON CORPORATION
-.--% | 01/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de V. Lawlis
| Sociétés | Poste | Début |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 01/06/2007 |
| GERON CORPORATION | Director/Board Member | 15/03/2012 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Director/Board Member | - |
Tspan LLC
 Tspan LLC Pharmaceuticals: MajorHealth Technology Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York. | Director/Board Member | 01/07/2017 |
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de V. Lawlis
| Sociétés | Poste | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director/Board Member | 22/06/2023 |
| COHERUS BIOSCIENCES, INC. | Director/Board Member | 22/05/2021 |
| SUTRO BIOPHARMA, INC. | Director/Board Member | 12/06/2019 |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Itero Holdings LLC provides investment services. The private company is based in San Jose, CA. | Chief Executive Officer | 01/01/2017 |
| ░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de V. Lawlis
| The University of Texas at Austin | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| GERON CORPORATION | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| SUTRO BIOPHARMA, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| ABSCI CORPORATION | Health Technology |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Itero Biopharmaceuticals, Inc. develops biopharmaceutical products for novel therapeutic proteins and antibodies. The firm focuses on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over marketed alternatives. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company was founded in 2006 by Dr. V. Bryan Lawlis Jr., Dr. Darlene P. Horton and Roy Jerald Beers and is headquartered in Mountain View, CA. | Health Technology |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Health Technology |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Health Technology |
Tspan LLC
Tspan LLC Pharmaceuticals: MajorHealth Technology Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York. | Health Technology |
Itero Holdings LLC
Itero Holdings LLC Financial ConglomeratesFinance Itero Holdings LLC provides investment services. The private company is based in San Jose, CA. | Finance |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a private company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Health Technology |
Itero Biopharmaceuticals LLC
 Itero Biopharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Itero Biopharmaceuticals LLC provides royalty payment services for licensing agreements. The American company was founded by V. Bryan Lawlis. | Commercial Services |
